We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Russian Vaccine Led to 100 Percent Antibody Generation, Trial Data Shows
Russian Vaccine Led to 100 Percent Antibody Generation, Trial Data Shows
Researchers from Moscow’s Gamaleya Research Institute have posted results from two phase 1/2 trials of their controversial COVID-19 vaccine, showing it was safe and induced the production of antibodies in all adult volunteers.